https://www.fiercebiotech.com/biotech/avalo-signals-change-fortunes-snapping-almatabio-its-ex-lilly-inflammatory-drug
Avalo snaps up AlmataBio for ex-Lilly inflammatory drug
Mar 28, 2024 - Avalo is handing over more than $22 million to acquire AlmataBio for a phase 2-ready monoclonal antibody for hidradenitis suppurativa.
avalosnapsexlillyinflammatory